Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Transcriptogen Ltd
Transcriptogen Ltd is an active company incorporated on 25 March 2013 with the registered office located in Cambridge, Cambridgeshire. Transcriptogen Ltd was registered 12 years ago.
Watch Company
Status
Active
Active since
incorporation
Company No
08461104
Private limited company
Age
12 years
Incorporated
25 March 2013
Size
Micro
Turnover is under
£1M
Balance sheet is under
£500,000
Under
10 employees
Confirmation
Submitted
Dated
5 April 2025
(5 months ago)
Next confirmation dated
5 April 2026
Due by
19 April 2026
(7 months remaining)
Last change occurred
5 months ago
Accounts
Submitted
For period
1 Jan
⟶
31 Dec 2024
(1 year)
Accounts type is
Total Exemption Full
Next accounts for period
31 December 2025
Due by
30 September 2026
(1 year remaining)
Learn more about Transcriptogen Ltd
Contact
Address
Unit 1, Cambridge House Camboro Business Park
Oakington Road, Girton
Cambridge
Cambridgeshire
CB3 0QH
United Kingdom
Same address for the past
7 years
Companies in CB3 0QH
Telephone
Unreported
Email
Unreported
Website
Unreported
See All Contacts
People
Officers
3
Shareholders
9
Controllers (PSC)
1
Dr Christopher Alan Keightley
Director • Biochemist • British • Lives in UK • Born in May 1954
Dr John Stephen Fox
Director • British • Lives in England • Born in Aug 1954
Professor David Edwin Thurston
Director • Professor Of Drug Discovery • British • Lives in UK • Born in May 1955
Dr Savvas Ioannou Neophytou
PSC • British • Lives in UK • Born in May 1972
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Orchard Vale Trust Limited
Dr John Stephen Fox is a mutual person.
Active
Portchester Healthcare Limited
Professor David Edwin Thurston is a mutual person.
Active
JMCA Research (UK) Ltd
Dr John Stephen Fox is a mutual person.
Active
Ferryx Limited
Dr John Stephen Fox is a mutual person.
Active
Cytolytix Limited
Professor David Edwin Thurston is a mutual person.
Active
Mango Therapeutics Limited
Dr Christopher Alan Keightley and Professor David Edwin Thurston are mutual people.
Dissolved
Phion Therapeutics Ltd
Dr John Stephen Fox is a mutual person.
In Administration
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period
31 Dec
⟶
31 Dec 2024
Traded for
12 months
Cash in Bank
£97.45K
Decreased by £14.82K (-13%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£111.45K
Decreased by £14.82K (-12%)
Total Liabilities
-£15.57K
Decreased by £80 (-1%)
Net Assets
£95.88K
Decreased by £14.74K (-13%)
Debt Ratio (%)
14%
Increased by 1.58% (+13%)
See 10 Year Full Financials
Latest Activity
Confirmation Submitted
5 Months Ago on 8 Apr 2025
Full Accounts Submitted
5 Months Ago on 20 Mar 2025
Confirmation Submitted
1 Year 5 Months Ago on 9 Apr 2024
Full Accounts Submitted
1 Year 5 Months Ago on 9 Apr 2024
Full Accounts Submitted
2 Years 2 Months Ago on 23 Jun 2023
Confirmation Submitted
2 Years 5 Months Ago on 5 Apr 2023
Savvas Ioannou Neophytou Resigned
2 Years 10 Months Ago on 7 Nov 2022
Confirmation Submitted
3 Years Ago on 19 Apr 2022
Accounting Period Extended
3 Years Ago on 19 Nov 2021
Full Accounts Submitted
3 Years Ago on 18 Nov 2021
Get Alerts
Get Credit Report
Discover Transcriptogen Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Confirmation statement made on 5 April 2025 with updates
Submitted on 8 Apr 2025
Total exemption full accounts made up to 31 December 2024
Submitted on 20 Mar 2025
Total exemption full accounts made up to 31 December 2023
Submitted on 9 Apr 2024
Confirmation statement made on 5 April 2024 with updates
Submitted on 9 Apr 2024
Total exemption full accounts made up to 31 December 2022
Submitted on 23 Jun 2023
Confirmation statement made on 5 April 2023 with updates
Submitted on 5 Apr 2023
Termination of appointment of Savvas Ioannou Neophytou as a director on 7 November 2022
Submitted on 18 Nov 2022
Confirmation statement made on 5 April 2022 with no updates
Submitted on 19 Apr 2022
Current accounting period extended from 31 July 2022 to 31 December 2022
Submitted on 19 Nov 2021
Total exemption full accounts made up to 31 July 2021
Submitted on 18 Nov 2021
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs